Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hypnion Inc.

Division of Eli Lilly & Co.

Latest From Hypnion Inc.

Finance Watch: Biomatics Closes Second VC Fund; SVB Buys Leerink To Expand Life Science Services

Scrip spoke with Managing Director Julie Sunderland about Biomatics' new $300m fund. Also, Silicon Valley Bank reveals its surprising Leerink buy, Perceptive Advisors raises $675m, Roivant brings in another $200m, and cell and gene therapy financings surge in the third quarter.

Financing StartUps and SMEs

Deal Statistics Quarterly, Q1 2007

We present another installment of our quarterly review of dealmaking-for January-March 2007. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics and research industries.
BioPharmaceutical Medical Device

European IPOs Hold Their Own

The conventional wisdom is that European biopharma IPOs lag those in the US both in number and average size, held back by fragmented markets, stingy risk-averse investors, and a lack of specialists. The wisdom's changed (or some of it, anyway).
BioPharmaceutical Europe

Lilly Doubles Down on Insomnia with Hypnion Acquisition

Eli Lilly added its second insomnia program with the acquisition of privately held Hypnion Inc. Hypnion's Phase II HY10275 compound is the industry's most advanced dual H1/5HT2a antagonist in clinical development. Hypnion management told START-UP that M&A was its preferred exit, given the resources necessary to develop HY10275 to its full potential.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System > Sleep Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Michael Fitzgerald, VP, Fin. & CFO
    Robert M Poole, MD, CMO
    Anita P Hoffer, PhD, VP, Bus. Dev.
  • Contact Info
  • Hypnion Inc.
    Phone: (781) 778-0300
    500 Patriot Way
    Lexington, MA 02421